SCHEMBL6314485

SCHEMBL6314485

CC1(C(=O)O)CSC(c2ccc(C(=O)O)cc2O)=N1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 2/20 0.40
CA12 O43570 1/20 0.40
CA1 P00915 1/20 0.40
CA2 P00918 1/20 0.40
POLB P06746 1/20 0.40
GAA P10253 1/20 0.40
MAPT P10636 1/20 0.40
CA4 P22748 1/20 0.40
CA6 P23280 1/20 0.40
PTGS2 P35354 1/20 0.40
CA7 P43166 1/20 0.40
CA9 Q16790 1/20 0.40
CA14 Q9ULX7 1/20 0.40
L3MBTL1 Q9Y468 1/20 0.40
RXRA P19793 6/20 0.37
RARB P10826 11/20 0.36
RARG P13631 10/20 0.36
RARA P10276 6/20 0.36
ALDH1A1 P00352 1/20 0.35
THRB P10828 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6314483 1.00 KDM4E (0.40) KDM4ECA12CA1CA2POLB
Deferitrin SCHEMBL1272026 0.86 TYR (0.35) KDM4ECA12CA1CA2POLB
SCHEMBL11963155 0.85 MEN1 (0.35) MAPTL3MBTL1HPGD
SCHEMBL6419881 0.83 HTR2B (0.36) KDM4EGAARXRARARBRARG
SCHEMBL3301483 0.82 NPC1 (0.40) KDM4EPOLBMAPTALDH1A1HPGD
SCHEMBL10331305 0.82 ACMSD (0.32) KDM4EPOLBGAAMAPTPTGS2
SCHEMBL13318367 0.82 ACMSD (0.32) KDM4EPOLBGAAMAPTPTGS2
SCHEMBL3301476 0.82 NPC1 (0.40) KDM4EPOLBMAPTALDH1A1HPGD
SCHEMBL6985974 0.81 KDM4E (0.37) KDM4ECA12CA1CA2POLB
SCHEMBL5525608 0.80 MAPT (0.36) CA12CA1CA2GAAMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6894170-B2 Process for the preparation of substituted thiazolines and their intermediates DSM FINE CHEMICALS AUSTRIA NFG GMBH & CO KG (AT) 2005-05-17 US disclosed
US-20050101782-A1 Process for the preparation of substituted thiazolines and their intermediates KRICH SYLVIA (AT) 2005-05-12 US disclosed
US-20030088105-A1 Process for the preparation of substituted thiazolines and their intermediates DSM FINE CHEMICALS AUSTRIA NFG GMBH & COKG (AT) 2003-05-08 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030088105-A1 Process for the preparation of substituted thiazolines and their intermediates CBR1, RCOR1, MT-CO1 KDM4E 4453/4885CA12 3420/4885CA1 1165/4885
US-20050101782-A1 Process for the preparation of substituted thiazolines and their intermediates CBR1, CBR3, MT-CO1 KDM4E 4582/4885CA12 2272/4885CA1 916/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.